![Christopher Anzalone](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Anzalone
Directeur Général chez
ARROWHEAD PHARMACEUTICALS, INC.
Fortune : 295 M $ au 31/05/2026
Profil
Christopher Richard Anzalone was the founder of Benet Group LLC, founded in 2005, where the title held was Chief Executive Officer.
Dr. Anzalone was also the founder of Nanotope, Inc...
Dr. Anzalone previously served as Chairman, President & Chief Executive Officer at Arrowhead Pharmaceuticals, Inc. since 2007.
Dr. Anzalone is a Director at Ablaris Therapeutics, Inc., Tego Biosciences Corp., and Arrowhead Madison, Inc. Former positions include Chief Executive Officer at NanoInk, Inc., Chairman & Chief Executive Officer at Calando Pharmaceuticals, Inc., and Director roles at Roche Madison, Inc., Kronos Bio, Inc., Vir Biotechnology, Inc., and Unidym, Inc. Dr. Anzalone was a Partner at Galway Partners LLC from 1999 to 2003.
Education includes a doctorate from the University of California, Los Angeles and an undergraduate degree from Lawrence University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/01/2026 | 3 792 739 ( 2,69 % ) | 295 M $ | 31/05/2026 |
Postes actifs de Christopher Anzalone
| Sociétés | Poste | Début |
|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | Directeur Général | 01/12/2007 |
Ablaris Therapeutics, Inc. | Directeur/Membre du Conseil | - |
Tego Biosciences Corp. | Directeur/Membre du Conseil | - |
Arrowhead Madison, Inc. | Directeur/Membre du Conseil | - |
Anciens postes connus de Christopher Anzalone
| Sociétés | Poste | Fin |
|---|---|---|
NanoInk, Inc.
 NanoInk, Inc. Industrial MachineryProducer Manufacturing Manufactures nanolithography tools and other nanoscale devices | President | 01/01/2004 |
Galway Partners LLC
 Galway Partners LLC Investment ManagersFinance Acts as an alternative investment manager | Corporate Officer/Principal | 01/01/2003 |
| KRONOS BIO, INC. | Directeur/Membre du Conseil | - |
| VIR BIOTECHNOLOGY, INC. | Directeur/Membre du Conseil | - |
Roche Madison, Inc.
 Roche Madison, Inc. Pharmaceuticals: MajorHealth Technology Provides gene transfer technologies to the pharmaceutical industry | Directeur/Membre du Conseil | - |
Formation de Christopher Anzalone
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
28
Relations au 1er degré
15
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
Arrowhead Pharmaceuticals, Inc.
 Arrowhead Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel drugs to treat intractable diseases | Health Technology |
NanoInk, Inc.
NanoInk, Inc. Industrial MachineryProducer Manufacturing Manufactures nanolithography tools and other nanoscale devices | Producer Manufacturing |
Calando Pharmaceuticals, Inc.
 Calando Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in the design and development of drug-delivery-enhanced small molecule therapeutics | Health Technology |
Nanotope, Inc.
 Nanotope, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lawrence University
 Lawrence University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roche Madison, Inc.
Roche Madison, Inc. Pharmaceuticals: MajorHealth Technology Provides gene transfer technologies to the pharmaceutical industry | Health Technology |
Unidym, Inc.
 Unidym, Inc. Electronic Production EquipmentElectronic Technology Develops and manufactures carbon nanotubes | Electronic Technology |
Benet Group LLC
 Benet Group LLC Financial ConglomeratesFinance Private equity firm | Finance |
Galway Partners LLC
Galway Partners LLC Investment ManagersFinance Acts as an alternative investment manager | Finance |
Ablaris Therapeutics, Inc. | |
Tego Biosciences Corp. | |
Arrowhead Madison, Inc. | |
Vir Biotechnology, Inc.
 Vir Biotechnology, Inc. BiotechnologyHealth Technology Develops cures and treatments drug for viral & bacterial diseases | Health Technology |
Kronos Bio, Inc.
 Kronos Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel cancer therapeutics | Health Technology |
